DrugInfoSys

Clobetasol (Propionate)

Drug #181

Clobetasol (Propionate) is a synthetic corticosteroid. Used topically for the relief of infalmmation and pruritis in corticosteroid responsive dermatoses. Clobetasol (Propionate) is a topical corticosteroid and used to treat swelling, inflammation, or itching of skin conditions such as eczema, dermatitis, rashes, insect bites, allergies and other irritations.

Primary Characteristics

It is of Synthetic origin and belongs to Steroid.

It belongs to Glucocorticoid agonist pharmacological group on the basis of mechanism of action and also classified in Corticosteroid Topical pharmacological group. It is also classified under Dermatological Products .

Molecular Weight: 467 · pKa: not ionizable · Solubility in Water: < 1 in 10000 · Solubility in Alcohol: 1 in 1000 · Non-proprietary name: Clobetasol (Propionate).

Molecular structure of Clobetasol (Propionate)

Pharmacokinetics

Elimination: it is metabolised via negligible, hepatic, renal excretion is only.

Advertisement

Indications

Contraindications

Dosage

Clobetasol (Propionate)'s dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
0.05 %0.05 %Every 12hTopicalApply sparingly to the affected area. Treatment should not be continued for more than 4 weeks without the condition of the patient being reviewed.
Paediatric Dosage (20kg)
0.05 %0.05 %Every 12hTopical -
Neonatal Dosage (3kg)
No data.

Drug Interactions

None recorded.

Side Effects

Clobetasol (Propionate) in overdosage may give rise to further complications which include Perioral rosacea , Psoriasis .

Clobetasol (Propionate) produces potentially life-threatening effects which include Cushing`s syndrome, Diabetes, Hypertension, Adrenal suppression. Careful monitoring is needed with proper medical management.

Clobetasol (Propionate) is known to cause more or less tolerable side effects which are usually transient. These include Dermal atrophy, Epidermal atrophy, Hypersensitivity reactions, Hypertrichosis , Pigmentation, Striae, Superficial blood vessels dilatation, Superficial blood vessels thinning.

Warnings / Precautions

Clobetasol should be used with caution in patients with active tuberculosis infection of respiratory tract or in untreated fungal, bacterial or systemic viral infections. Corticosteroids should only be used systemically with great caution in the presence of congestive heart failure (CHF), recent myocardial infraction (MI), hypertension, diabetes mellitus, epilepsy, glaucoma, hypothyroidism, liver failure, osteoporosis, peptic ulceration or renal impairment. Children may be at increase risk of some adverse effects, corticosteroid causes growth retardation and prolonged use is rarely justified. Passive immunization is recommended to non-immune patients who do come in contact with chickenpox or measles. Live vaccine should not be given to patients receiving high dose systemic corticosteroid therapy nor for atleast 3 months afterwards, killed vaccine or toxoids may be given, although the response may be attenuated. During prolong treatment with corticosteroids, patients should be examined regularly, sodium intake may need to be reduced and calcium and potassium supplement may be necessary. Patient should carry cards given full details of their corticosteroid therapy. Avoid use during pregnancy. Use nasal steroids with caution until healing has occurred.

Interference in Pathology

Clobetasol (Propionate) may interfere in the diagnosis of Plasma Cortisol Test , ACTH Stimulation test, ACTH stimulation test.

Available Brands

Click on a strength to view available brands.

Single Ingredient

Multi-Ingredient Combinations

Storage Conditions

Clobetasol (Propionate) should be stored Gel, Cream, Oint.

Drug Classification

  1. 1.13.3.1Corticosteroids plain
  2. 2.13.3.2Corticosteroids combinations

Manufacturers